Price (delayed)
$26.37
Market cap
$4.28B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.75
Enterprise value
$5.7B
BridgeBio Pharma Inc. is a team of experienced drug discoverers, developers and innovators working to create life-altering medicines that target well-characterized genetic diseases at their source. BridgeBio was founded in
There are no recent dividends present for BBIO.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.